Representative Gilbert Ray Cisneros of California has attracted attention following his purchase of SpaceX (NASDAQ: SPCX) stock shortly after the company’s initial public offering (IPO). Filings reveal that on June 18, Cisneros acquired between $1,001 and $15,000 worth of shares, a move disclosed on July 2 as required by law.

The timing of his stock acquisition raises eyebrows, particularly because Cisneros is a member of the House Armed Services Committee, which oversees defense spending and military-related programs. SpaceX is known for its significant contracts with the Department of Defense and NASA.

Details of the Stock Purchase

Cisneros purchased SPCX shares just six days post its Nasdaq debut on June 12. The share price had already increased from the IPO price of $135 to over $225 by the time of his trade, before correcting to $162 at the time of reporting. This transaction occurred near the peak of the stock’s rally following its IPO.

Since then, SPCX shares have declined approximately 12.4%, contrasting with the broader market decline of less than 1% during the same timeframe. Although the purchase amount was relatively small, the timing is significant, considering the high-profile nature of SpaceX’s IPO.

Cisneros’ Broader Trading Activity

The SpaceX investment is part of a series of stock transactions reported by Cisneros, indicating his active trading status in Congress. Recent filings reveal up to $2.5 million in new trades across various sectors, including notable purchases in companies like Cadre Holdings (NYSE: CDRE) and Eli Lilly and Company (NYSE: LLY).

Public records indicate that Cisneros engages in frequent trading across technology, defense, healthcare, and industrial sectors. While congressional stock trading remains legal under the STOCK Act's disclosure rules, transactions involving companies with significant government contracts often draw scrutiny from ethics watchdogs.

Calls for Stricter Regulations

The disclosure of Cisneros’ trades comes amid increasing calls for stricter regulations governing congressional investments. Proposed measures include banning Congress members from owning or trading individual stocks, as concerns about potential conflicts of interest and insider trading continue to arise.